Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 330.2	$ 375.7
Accounts receivable, less allowance for credit losses	1,380.9	1,381.5
Inventories	2,241.3	2,147.2
Prepaid expenses and other current assets	459.5	522.9
Total Current Assets	4,411.9	4,427.3
Property, plant and equipment, net	1,906.4	1,872.5
Goodwill	8,734.9	8,580.2
Intangible assets, net	5,071.7	5,063.8
Other assets	1,118.6	1,122.2
Total Assets	21,243.5	21,066.0
Current Liabilities:
Accounts payable	397.1	354.1
Income taxes payable	46.6	38.5
Salaries, wages and benefits	234.2	336.2
Other current liabilities	1,072.9	1,085.1
Current portion of long-term debt	585.0	544.3
Total Current Liabilities	2,335.9	2,358.2
Deferred income taxes, net	484.6	474.8
Long-term income tax payable	423.3	421.2
Other long-term liabilities	637.4	632.6
Long-term debt	5,204.8	5,152.2
Total Liabilities	9,085.9	9,039.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 315.4 million shares in 2023 (313.8 million in 2022) issued	3.2	3.1
Paid-in capital	9,692.4	9,504.4
Retained earnings	9,741.7	9,559.3
Accumulated other comprehensive loss	(178.0)	(179.3)
Treasury stock, 106.9 million shares as of March 31, 2023 (104.8 million as of December 31, 2022)	(7,108.6)	(6,867.2)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,150.7	12,020.3
Noncontrolling interest	6.9	6.7
Total Stockholders' Equity	12,157.6	12,027.0
Total Liabilities and Stockholders' Equity	$ 21,243.5	$ 21,066.0